Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07464119
NA
A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy
Sponsor: Peking University First Hospital
View on ClinicalTrials.gov
Summary
This is a single-arm, open-label clinical trial designed to assess the safety and therapeutic efficacy of iPSC-derived islet cell infusion in patients with diabetes mellitus.
Official title: A Single-Arm, Open-Label Clinical Study of iPSC-Derived Islet Cells for the Treatment of Diabetes Mellitus
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-03-16
Completion Date
2033-12-31
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
iPSC-derived islet cell
iPSC-derived islet cell infusion
Locations (1)
Peking University First Hospital
Beijing, China